findmyKOL
Clinical trialNCT06086522RecruitingPhase 1Interventional

Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

SponsorQualigen Theraputics, Inc.Enrollment54Solid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Honorhealth

    Scottsdale, Arizona, United States

    Erkut Borazanci, MD
    Recruiting
  • Yale

    New Haven, Connecticut, United States

    Patricia LoRusso, DO
    Not, yet, recruiting
  • Start Midwest

    Grand Rapids, Michigan, United States

    Sreenivasa Chandana, MD
    Recruiting
  • Md Anderson Cancer Center

    Houston, Texas, United States

    Jordi Rodon, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Nov 2023
Primary completion
31 Dec 2025
Completion
31 Dec 2026
Last update posted
1 May 2024
Registered enrollment
54
Registry id
NCT06086522
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.